Tue, Sep 23, 2014, 9:06 AM EDT - U.S. Markets open in 24 mins.


% | $
Quotes you view appear here for quick access.

Merrimack Pharmaceuticals, Inc. (MACK) Message Board

  • gmns888 gmns888 Oct 30, 2013 9:11 AM Flag

    Here is clip from few months ago

    The culprit for Merrimack's shares falling still seems to be disappointment from its interim review of clinical studies for experimental drug MM-121, which is in development with Sanofi. Merrimack announced last week that primary endpoints probably would not be met for a study of MM-121 in treating ovarian cancer, and another study in treating wild type non-small-cell lung cancer. The company also reported a worse-than-expected net loss in its second-quarter financial update last week.

7.170.00(0.00%)Sep 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.